MedTrace Logo

Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract

NCT04014699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2020-09-16

No results posted yet for this study

Summary

This study is a single-center, parallel-group, randomized controlled trial with the following objectives: to compare the incidence of post-operative descemet membrane detachment (DMD) in phacoemulsification surgery between modified and conventional 2.2mm microincision.

Conditions

  • Cataract

Interventions

PROCEDURE

modified 2.2mm microincision

enlarging the internal incision about 0.4mm for conventional 2.2mm coaxial microincision phacoemulsification

PROCEDURE

conventional 2.2mm microincision

conventional 2.2mm coaxial microincision phacoemulsification

Sponsors & Collaborators

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Yizhi Liu, PhD · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-22
Primary Completion
2019-10-22
Completion
2020-01-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014699 on ClinicalTrials.gov